VERMOX
- Product NDC
- 50458-675
- 11-digit product format
- 504580675
- Labeler code
- 50458
- Product ID
- 50458-675_5757cf97-389e-4199-8b53-d32a18e55800
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- mebendazole
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Labeler
- Janssen Pharmaceuticals, Inc.
- Application
- NDA208398
- Marketing category
- NDA
- Marketing start
- 2016-10-20
- Substance
- MEBENDAZOLE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anthelmintic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- VERMOX
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MEBENDAZOLE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 81G6I5V05I |
| Rxcui | 1855385, 1855387 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50458-675-20 | VERMOX | 200 in 1 BOTTLE | TABLET, CHEWABLE | 200 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50458-675 | VERMOX (MEBENDAZOLE) TABLET, CHEWABLE [JANSSEN PHARMACEUTICALS, INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20211006_a720c424-517a-461b-8e13-6c37caf8aa3f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50458-675-20 | 50458067520 | 200 TABLET, CHEWABLE in 1 BOTTLE (50458-675-20) | 2016-10-20 | 0000-00-00 | No | No | Current |